Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine

Parasite Immunol. 2012 Jan;34(1):40-4. doi: 10.1111/j.1365-3024.2011.01341.x.

Abstract

Although immunity to Echinococcus granulosus in sheep has been shown to be antibody-mediated and complement-dependent and can be passively transferred in colostrum, in animals vaccinated with EG95, the relationship between protection against an oral challenge infection with E. granulosus eggs and anti-EG95 IgG ELISA absorbance values at the time of challenge has not been satisfactorily proven. Using a combination of results from three EG95 vaccination trials, we have found that the IgG ELISA absorbance at the time of challenge infection explains approximately 50% (P ≤ 0·001) of the variability in the percentage protection against an oral challenge with E. granulosus eggs (transformed with arcsin).

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Antibodies, Helminth / blood*
  • Antigens, Helminth / immunology*
  • Biomarkers
  • Echinococcosis / immunology
  • Echinococcosis / prevention & control
  • Echinococcosis / veterinary*
  • Echinococcus granulosus / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Helminth Proteins / immunology*
  • Immunoglobulin G / blood
  • Sheep
  • Sheep Diseases / immunology
  • Sheep Diseases / prevention & control*
  • Vaccines / administration & dosage*
  • Vaccines / immunology*

Substances

  • Antibodies, Helminth
  • Antigens, Helminth
  • Biomarkers
  • EG95 protein, Echinococcus granulosus
  • Helminth Proteins
  • Immunoglobulin G
  • Vaccines